Solaris Endovascular Announces Completion of Enrollment in DEScover Trial
Enrollment milestone achieved ahead of schedule as Solaris DE drug-eluting continues to gather additional clinical evidence of safety and performance. NEW ORLEANS, LA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Solaris Endovascular, …